Skip to search.
 TSX Up 0.76% TSX Ventures Up 0.50%

Celgene Corporation (CELG)

-NasdaqGS
110.55 Up 2.49(2.30%) May 1, 4:00PM EDT
|After Hours : 111.00 Up 0.45 (0.41%) May 1, 7:29PM EDT
Add to Portfolio
Prev Close:108.06
Open:108.06
Bid:110.80 x 500
Ask:111.12 x 100
1y Target Est:138.17
Beta:1.82
Earnings Date:Jul 22 - Jul 27 (Est.)
Day's Range:108.02 - 112.00
52wk Range:71.32 - 129.06
Volume:6,594,911
Avg Vol (3m):5,638,490
Market Cap:88.51B
P/E (ttm):46.26
EPS (ttm):2.39
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGUp 2.30%88.51B
JNJUp 0.94%278.42B

Key Statistics

Forward P/E (1 yr):17.60
P/S (ttm):11.28
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :4.77
Quarterly EPS Est (Jun-15) :1.16
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.92

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback